Anti-Hmgb1 Antibodies and Alpha-7 Agonists as Experimental Therapeutics as BW Countermeasures

doi 10.21236/ada459623
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Anti-Caveolin-1 Antibodies as Anti-Prostate Cancer Therapeutics

Hybridoma
2012English

Monoclonal and Bispecific Antibodies as Novel Therapeutics

Archivum Immunologiae et Therapiae Experimentalis
MedicineAllergyImmunology
2006English

PPAR Agonists: Potential as Therapeutics for Neovascular Retinopathies

PPAR Research
Drug DiscoveryPharmacology
2008English

Discovery of Anti-Claudin-1 Antibodies as Candidate Therapeutics Against Hepatitis C Virus

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2015English

Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics

Journal of Clinical Investigation
Medicine
2013English

PPARγ Agonists as Therapeutics for the Treatment of Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2008English

Anti-Transcription Factor RNA Aptamers as Potential Therapeutics

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2016English

Estrogen-Related Receptor Alpha (ERRa)-Coactivator Interactions as Targets for Discovery of New Anti-Breast Cancer Therapeutics

2006English

The Promise of Anti-ErbB3 Monoclonals as New Cancer Therapeutics

Oncotarget
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy